◆ 会议时间：2026年7月10-12日
◆ 会议地点：印度尼西亚 巴厘岛

◆ 会议简介：

2026年亚太重症医学研讨会(APICS)将于2026年7月10-12日在印度尼西亚巴厘岛举行。APICS原为SG-ANZICS亚太危重病医学论坛(“SG-ANZICS”或“#SGANZICS”)，是由新加坡危重病医学会(SICM)与澳大利亚和新西兰危重病医学会(ANZICS)联合发起的在新加坡召开的危重症医学学术会议，是亚太地区首屈一指的临床ICU国际盛会，致力于为所有重症监护医疗保健提供者提供一个交流、学习和进步宣的平台，促进区域重症医学协会之间的合作，尽而改善亚太地区和世界危重病患者的护理和预后；预计有近1000名代表参加本次会议。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）.

APICS 2026 - Asia Pacific Intensive Care Symposium (APICS by SICM X ANZICS)

Date:
July 10-12, 2026
Pre-Symposium Workshops: July 8-9, 2026

Venue:
Bali Nusa Dua Convention Center (BNDCC), Indonesia

Organized by:
Indonesian Society of Intensive Care Medicine (ISICM)
Society of Intensive Care Medicine, Singapore (SICM)
Australian and New Zealand Intensive Care Society (ANZICS)

Since its inception in 2014, the Asia Pacific Intensive Care Symposium (APICS) has grown into a leading platform for the critical care community across the region. From its early days as the SG-ANZICS Forum in Singapore to its evolution into APICS in 2021, the symposium has consistently championed innovation, collaboration, and clinical excellence in intensive care.

Now in its 13th edition, APICS 2026 will mark an exciting new chapter as it takes place for the first time outside Singapore, heading to the beautiful island of Bali, Indonesia. Set against a backdrop of tropical serenity, APICS 2026 will continue to bring together intensivists, nurses, allied health professionals, and researchers to share insights, explore emerging challenges, and shape the future of critical care.

摘要征文投稿：

ABSTRACT SUBMISSION GUIDELINES

• Abstracts may be submitted for poster or oral presentation only.
• Abstracts must be submitted online via the Symposium website. Abstracts submitted by fax, email, or post will NOT be accepted.
• Abstracts must be submitted by 9 March 2026. The online submission system will close at 2359 GMT+8 on this day.
• Please do not submit multiple copies of the same abstract.
• The work in the abstract should not be presented nor appear in another format at any international meeting before APICS 2026. It should not be published, in whole, or in an abstract, in a scientific journal.
• If Artificial Intelligence (AI) tools have been used, at any point, in the process of the research or the writing of the abstract, it must be clearly disclosed in the abstract text.
• No changes/edits will be possible after the submission deadline.
• Original research abstracts submitted must adhere to the Declaration of Helsinki ethical principles for medical research. This requires that all research (clinical or experimental in humans or animals) must have the approval or an exemption from a suitable Institutional Review Board (IRB), Independent Ethics Committee (IEC), or Ethical Review Board (ERB).
• Submitters are required to obtain patient consent for case reports and be aware of patient confidentiality before submission of abstracts.

点此提交摘要>>>Submit Abstract>>>

CONFIRMATION OF RECEIPT AND NOTIFICATION OF DECISION

• After submitting your abstract, you will receive an email confirmation that your abstract has been received.
• Please contact the Secretariat at abstract@sg-apics.com if you have submitted an abstract and did not receive an email acknowledgement.
• Notifications regarding the status of your abstract acceptance will be sent out by 30 March 2026 onwards .

PRESENTATION AT THE CONGRESS

• Instructions for preparation of poster presentations will be sent together with the acceptance notification.
• The Organising Committee will endeavour to schedule abstracts according to authors’ preferences but reserves the right to decide on the final form of presentation.
• For each abstract, at least one author is expected to attend the symposium.
• Abstract presenters need to register by the registration deadline for inclusion in the symposium programme and the presentation schedule.

PREPARING YOUR ABSTRACT FOR SUBMISSION

• The abstract should be as informative as possible and include the following details in concise statements:
  • Objectives: Background and specific aims of the study
  • Methods: Description of methods used
  • Results: Summary of results obtained
  • Conclusions: Conclusions reached
• For case reports, the abstract presented should contain the following:
  • Background: Describe the underlying clinical question, including a brief statement summarising why this case is noteworthy.
  • Case report: Summarise the history, key examination and investigation findings; treatment/management; and the patient’s condition after treatment.
  • Discussion: Explain the significance and objective of reporting the case; summarise relevant literature; and support your key message with evidence.
  • Conclusion and learning points
• Abstracts must meet the following specifications:
  • Abstract title – Limited to 25 words
  • Abstract text – Limited to 300 words
  • Abstract topic – Abstract topic must be chosen from a specific theme listed in the Scientific Programme
• You may upload 1 graphic/image for your abstract.
• Use only standard abbreviations. Special or unusual abbreviations are not recommended. If otherwise necessary, the latter should be placed in parenthesis after the first appearance of the full word.
• All abstracts must be submitted and presented in clear English with accurate grammar and spelling of a quality suitable for publication. If you need editorial help, please arrange for the review of your abstract by a colleague who is a native English speaker, by a university scientific publications office (or other similar facility), or by a copy editor, prior to submission.
• The submission link at the top of this page allows you to store your abstract in draft form to facilitate edits. Please note that abstracts must be submitted before the deadline to be sent for review for inclusion in the Scientific Programme.

DECLARATION OF CONSENT TO PUBLICATION AND ASSIGNATION OF COPYRIGHT

Please take note of the following terms:

• The submitted abstract cannot be modified or corrected after the submission deadline has closed. The Abstract Submitter understands that it will be published as submitted.
• Submission of the abstract constitutes the consent of all authors to publication (e.g. APICS 2026 website, programme, and other promotional materials).
• The Abstract Submitter warrants and represents that no part of the information and content provided by him/her (hereafter referred to as the “Content”) to APICS 2026 and Kenes MP Asia (hereafter referred to as the “Organisers”), nor the publication of any such Content by the Organisers, on the internet or otherwise, infringes any third-party rights, including, but not limited to, privacy rights and/or intellectual property rights.
• The Abstract Submitter grants the Organisers a copyright license to reproduce, publish, translate, distribute, and display the text of the Content on a royalty-free, perpetual, irrevocable, nonexclusive basis.
• The Abstract Submitter is responsible for informing the other authors about the status of the abstract.
• The Organisers reserve the right to remove from publication and/or presentation any abstract which does not comply with the above terms.

注册费：

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。